{"name": "Oncos Therapeutics",
 "permalink": "oncos-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/oncos-therapeutics",
 "homepage_url": "http://www.oncos.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@oncostherapeutics.com",
 "phone_number": "",
 "description": "",
 "created_at": "Thu May 06 02:09:00 UTC 2010",
 "updated_at": "Wed Jul 07 09:06:56 UTC 2010",
 "overview": "\u003Cp\u003EOncos Therapeutics develops new cancer therapies based on its next generation oncolytic viruses. The company\u00e2\u20ac\u2122s unique Advanced Therapy Access Program was started in 2007 for cancer patients in whom standard-of-care therapies have failed. Today, 200 patients have undergone individually tailored oncolytic virus therapy suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for ongoing clinical development.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       86],
      "assets/images/resized/0008/6146/86146v1-max-150x150.png"],
     [[250,
       144],
      "assets/images/resized/0008/6146/86146v1-max-250x250.png"],
     [[260,
       150],
      "assets/images/resized/0008/6146/86146v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-founder, CEO",
    "person":
     {"first_name": "Pekka",
      "last_name": "Simula",
      "permalink": "pekka-simula",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Timo",
      "last_name": "Ahopelto",
      "permalink": "timo-ahopelto",
      "image":
       {"available_sizes":
         [[[113,
            135],
           "assets/images/resized/0001/7965/17965v1-max-150x150.jpg"],
          [[113,
            135],
           "assets/images/resized/0001/7965/17965v1-max-250x250.jpg"],
          [[113,
            135],
           "assets/images/resized/0001/7965/17965v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$5.5M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://onbiovc.com/oncos-therapeutics-ltd-series-c-55m/",
    "source_description": "Oncos Therapeutics, Ltd.: Series C $5.5M",
    "raised_amount": 5500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Tukholmankatu 8 A",
    "address2": "",
    "zip_code": "FI-00290",
    "city": "Helsinki",
    "state_code": null,
    "country_code": "FIN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}